Rosana Kapeller
Person ● Covered in 0 stories + Follow ✴ AI Graph Request update
Dr. Rosana Kapeller is an entrepreneur-in-residence at GV, where she joined in 2018 as the firm’s first life sciences entrepreneur-in-residence. At GV, she incubated the idea that became ROME Therapeutics, a company developing therapies that target the repeatome in oncology and autoimmune disease. Earlier in her career, she was founding Chief Scientific Officer of Nimbus Therapeutics, co-founder and VP of Research at Aileron Therapeutics, and spent ten years at Millennium Pharmaceuticals, with additional consulting work for Third Rock Ventures and Atlas Venture. She is known for advancing the concept of targeting the repeatome for drug discovery and for helping apply computational technologies to the design and development of therapeutics.
Updated 4 September 2026
Public sources: gv.com
Why this page exists, and how to correct or remove it
This profile is assembled automatically because Rosana Kapeller appears in coverage we index or holds a role listed publicly by their organisation. It uses only public sources — company and organisation pages, news articles, Wikipedia, and public professional listings — and the biography, if any, is written by AI from those sources and cited above.
We hold it to report on the AI industry, under the legitimate interest of journalistic reporting. You can ask us to correct it, restrict it, or take it down, and you can object at any time — no account needed, no reason required.
Claim or correct this profile Request removal How we handle personal data